$BNTX &amp; $PFE announce completion of dosing for first cohort of Phase 1/2 trial of #COVID19 vaccine candidates in Germany.
Plan to initiate trials in the U.S upon regulatory approval which is expected shortly.

https://t.co/BHlZfWpNww #coronavirus